What are all the active Destiny 2 codes? Emblems are essential to authentic Guardian flair. They offer an opportunity for expression among your fireteam, the random Guardians you encounter in the ...

Australia’s leading independent law firm, Corrs Chambers Westgarth, has advised Cosette Pharmaceuticals, Inc (Cosette) on its pending A$672 million acquisition of Mayne Pharma Group Limited (Mayne) ...

Bridgewater-based Cosette Pharmaceuticals announced Feb. 20 it entered into an agreement to acquire Mayne Pharma Group Ltd. in a $430 million deal. Mayne is an Australian-headquartered specialty ...

Bungie has turned a Destiny 2 bug that mistakenly made class-locked Exotic weapons available to all into a feature. Whilst acknowledging the team "won't always look at weird bugs and decide to ...

Nicole Carpenter is a senior reporter specializing in investigative features about labor issues in the game industry, as well as the business and culture of games. Political commentary streamer ...

Bridgewater-based Cosette Pharmaceuticals, Inc., a fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of ...

The news: ASX small cap Mayne Pharma saw its shares surge more than 30% after US-based Cosette Pharmaceuticals agreed to acquire the Adelaide-based specialty pharmaceutical company. The numbers: Mayne ...

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Private equity-backed US pharmaceutical giant Cosette has made a $672 million cash takeover bid for women’s health and dermatology group Mayne Pharmaceuticals. The company, which last week ...

Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne ...

With a $430 million buyout of Australia’s Mayne Pharma locked down, Cosette Pharmaceuticals is looking to become a leading force in women’s healthcare. The New Jersey-based drugmaker agreed to ...

Mayne told shareholders that in the absence of a better offer, the board had unanimously agreed to a scheme of arrangement with ­Cosette at $7.40 a share cash, 37 per cent higher than Thursday ...